Showing 481-490 of 1697 results for "".
In-Focus: Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/in-focus-parkinsons-disease/30471/The Most Unsettling Trends Facing Physicians: What to Expect and What to Do Today
https://practicalneurology.com/columns/practice-management/the-most-unsettling-trends-facing-physicians-what-to-expect-and-what-to-do-today/30764/The right approaches to financial planning can help protect and grow a physician's assets, even as troubling trends persist.Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.In-Hospital Blood Pressure Control After Acute Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/in-hospital-blood-pressure-control-after-acute-ischemic-stroke/31860/Blood pressure control plays an important role in stroke outcomes.Autoimmune Movement Disorders in Adults
https://practicalneurology.com/diseases-diagnoses/movement-disorders/autoimmune-movement-disorders-in-adults/31702/As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.Study Shows Promise for LRRK2 Inhibitor Approach to Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/study-shows-promise-for-lrrk2-inhibitor-approach-to-parkinsons/30644/Research is focusing on the LRRK2 gene as a means of neuroprotection.The Many Challenges of Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-many-challenges-of-drug-resistant-epilepsy/31834/Recognizing and appropriately treating drug-resistant epilepsy is paramount.Letters
https://practicalneurology.com/columns/practice-management/letters/30698/VZV Vaccination for the Prevention of PHN
https://practicalneurology.com/columns/practice-management/vzv-vaccination-for-the-prevention-of-phn/30738/A majority of individuals age 50 or older could potentially avoid shingles or post-herpetic neuralgia.Antiplatelet Therapy and Lacunar Stroke: Still a Match
https://practicalneurology.com/diseases-diagnoses/stroke/antiplatelet-therapy-and-lacunar-stroke-still-a-match/30550/A new meta-analysis does not support dual-antiplatelet therapy, but monotherapy may help.